Iron oxide nanoparticle targeted chemo-immunotherapy for triple negative breast cancer

Cancer statistics, 2020

(2020) Rebecca L. Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with solvent-based taxanes for metastatic breast cancer: A meta-analysis

(2020) Hwaryeon Lee et al.   Scientific Reports

Nanoparticle-enhanced chemo-immunotherapy to trigger robust antitumor immunity

(2020) Jingjing Liang et al.   Science Advances

Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

(2019) Jérôme Galon et al.   NATURE REVIEWS DRUG DISCOVERY

Bioinspired Core-Shell Nanoparticles for Hydrophobic Drug Delivery

(2019) Guangze Yang et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

Hydrophobic drug self-delivery systems as a versatile nanoplatform for cancer therapy: A review

(2019) Peng Xue et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Triple‐negative breast cancer—Role of immunology: A systemic review

(2019) Gizem Oner et al.   Breast Journal

Dual pH-responsive multifunctional nanoparticles for targeted treatment of breast cancer by combining immunotherapy and chemotherapy

(2018) Yuanyuan Liu et al.   Acta Biomaterialia

Engineering nanoparticle strategies for effective cancer immunotherapy

(2018) Hong Yeol Yoon et al.   BIOMATERIALS

Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1

(2018) Chia-Wei Li et al.   CANCER CELL

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer

(2018) Peter Schmid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Lipid–Drug Conjugate for Enhancing Drug Delivery

(2017) Danielle Irby et al.   MOLECULAR PHARMACEUTICS

Immunogenic Cell Death Amplified by Co-localized Adjuvant Delivery for Cancer Immunotherapy

(2017) Yuchen Fan et al.   NANO LETTERS

Multivalent bi-specific nanobioconjugate engager for targeted cancer immunotherapy

(2017) Hengfeng Yuan et al.   Nature Nanotechnology

T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity

(2017) Daniela Schmid et al.   Nature Communications

Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy

(2017) Guizhi Zhu et al.   Nature Communications

A high-density lipoprotein-mediated drug delivery system

(2016) Zhong-Cheng Mo et al.   ADVANCED DRUG DELIVERY REVIEWS

Enhanced Delivery of Plasmid Encoding Interleukin-12 Gene by Diethylene Triamine Penta-Acetic Acid (DTPA)-Conjugated PEI Nanoparticles

(2016) Ali Dehshahri et al.   APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY

The Nuclear Pore Complex as a Flexible and Dynamic Gate

(2016) Kevin E. Knockenhauer et al.   CELL

Engineering nanolayered particles for modular drug delivery

(2016) Santiago Correa et al.   JOURNAL OF CONTROLLED RELEASE

Restoring anti-tumor functions of T cells via nanoparticle-mediated immune checkpoint modulation

(2016) Shi-Yong Li et al.   JOURNAL OF CONTROLLED RELEASE

Nanoparticle–liver interactions: Cellular uptake and hepatobiliary elimination

(2016) Yi-Nan Zhang et al.   JOURNAL OF CONTROLLED RELEASE

Acid-Activatable Versatile Micelleplexes for PD-L1 Blockade-Enhanced Cancer Photodynamic Immunotherapy

(2016) Dangge Wang et al.   NANO LETTERS

Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy

(2016) Matthias A. Oberli et al.   NANO LETTERS

Hyaluronic acid-coated PEI-PLGA nanoparticles mediated co-delivery of doxorubicin and miR-542-3p for triple negative breast cancer therapy

(2016) Shengpeng Wang et al.   Nanomedicine-Nanotechnology Biology and Medicine

Designer vaccine nanodiscs for personalized cancer immunotherapy

(2016) Rui Kuai et al.   NATURE MATERIALS

Combine and conquer: challenges for targeted therapy combinations in early phase trials

(2016) Juanita S. Lopez et al.   Nature Reviews Clinical Oncology

Triple-negative breast cancer: is there a treatment on the horizon?

(2016) Hui Yao et al.   Oncotarget

Gemcitabine and chlorotoxin conjugated iron oxide nanoparticles for glioblastoma therapy

(2016) Qingxin Mu et al.   Journal of Materials Chemistry B

Analysis of nanoparticle delivery to tumours

(2016) Stefan Wilhelm et al.   Nature Reviews Materials

Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer

(2016) Yumin Zhang et al.   Scientific Reports

Polyelectrolyte Multilayers Assembled Entirely from Immune Signals on Gold Nanoparticle Templates Promote Antigen-Specific T Cell Response

(2015) Peipei Zhang et al.   ACS Nano

Engineering Polymer Hydrogel Nanoparticles for Lymph Node-Targeted Delivery

(2015) Stefaan De Koker et al.   ANGEWANDTE CHEMIE-INTERNATIONAL EDITION

CXCR4-Targeted Nanocarriers for Triple Negative Breast Cancers

(2015) Asish C. Misra et al.   BIOMACROMOLECULES

Size dependent biodistribution and toxicokinetics of iron oxide magnetic nanoparticles in mice

(2015) Lin Yang et al.   Nanoscale

Principles of nanoparticle design for overcoming biological barriers to drug delivery

(2015) Elvin Blanco et al.   NATURE BIOTECHNOLOGY

In situ vaccination with cowpea mosaic virus nanoparticles suppresses metastatic cancer

(2015) P. H. Lizotte et al.   Nature Nanotechnology

Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease

(2015) Murugan Kalimutho et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

An Iron Oxide Nanocarrier Loaded with a Pt(IV) Prodrug and Immunostimulatory dsRNA for Combining Complementary Cancer Killing Effects

(2015) Javier Hernández-Gil et al.   Advanced Healthcare Materials

T Lymphocyte Inhibition by Tumor-Infiltrating Dendritic Cells Involves Ectonucleotidase CD39 but Not Arginase-1

(2015) Malika Trad et al.   Biomed Research International

Nanoparticle-Based Immunotherapy for Cancer

(2014) Kun Shao et al.   ACS Nano

Layer-by-layer assembly of liposomal nanoparticles with PEGylated polyelectrolytes enhances systemic delivery of multiple anticancer drugs

(2014) Thiruganesh Ramasamy et al.   Acta Biomaterialia

Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer

(2014) Xiongwei Deng et al.   BIOMATERIALS

New insights into IL-12-mediated tumor suppression

(2014) S Tugues et al.   CELL DEATH AND DIFFERENTIATION

SGN-LIV1A: A Novel Antibody-Drug Conjugate Targeting LIV-1 for the Treatment of Metastatic Breast Cancer

(2014) D. Sussman et al.   MOLECULAR CANCER THERAPEUTICS

Treatment of 4T1 Metastatic Breast Cancer with Combined Hypofractionated Irradiation and Autologous T-Cell Infusion

(2014) Alexander Filatenkov et al.   RADIATION RESEARCH

In Vivo Tumor Targeting and Image-Guided Drug Delivery with Antibody-Conjugated, Radiolabeled Mesoporous Silica Nanoparticles

(2013) Feng Chen et al.   ACS Nano

Tumor vasculature targeting and imaging in living mice with reduced graphene oxide

(2013) Sixiang Shi et al.   BIOMATERIALS

Doxorubicin-Induced Cardiotoxicity: From Bioenergetic Failure and Cell Death to Cardiomyopathy

(2013) Filipa S. Carvalho et al.   MEDICINAL RESEARCH REVIEWS

Paclitaxel–Hyaluronic NanoConjugates Prolong Overall Survival in a Preclinical Brain Metastases of Breast Cancer Model

(2013) Rajendar K. Mittapalli et al.   MOLECULAR CANCER THERAPEUTICS

The Preventive Oral Supplementation of a Selenium Nanoparticle-enriched Probiotic Increases the Immune Response and Lifespan of 4T1 Breast Cancer Bearing Mice

(2012) M. Yazdi et al.   ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH

Increased Expression of P-Glycoprotein Is Associated with Doxorubicin Chemoresistance in the Metastatic 4T1 Breast Cancer Model

(2011) Lili Bao et al.   AMERICAN JOURNAL OF PATHOLOGY

Anticancer function of polyinosinic-polycytidylic acid

(2011) Yu-sheng Cheng et al.   CANCER BIOLOGY & THERAPY

Positron emission tomography imaging of CD105 expression during tumor angiogenesis

(2011) Hao Hong et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Induction of CD8+ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma

(2010) Hideho Okada et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

(2010) Matthias T Stephan et al.   NATURE MEDICINE

The safety and side effects of monoclonal antibodies

(2010) Trevor T. Hansel et al.   NATURE REVIEWS DRUG DISCOVERY

Triple-Negative Breast Cancer

(2010) William D. Foulkes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Doxorubicin in Combination with a Small TGFβ Inhibitor: A Potential Novel Therapy for Metastatic Breast Cancer in Mouse Models

(2010) Abhik Bandyopadhyay et al.   PLoS One

Classification of Chemotherapeutic Agents Based on Their Differential In vitro Effects on Dendritic Cells

(2009) H. Tanaka et al.   CANCER RESEARCH

Breast Cancer Metastasis: Challenges and Opportunities

(2009) J. Lu et al.   CANCER RESEARCH

Anti-endoglin monoclonal antibodies are effective for suppressing metastasis and the primary tumors by targeting tumor vasculature

(2009) Shima Uneda et al.   INTERNATIONAL JOURNAL OF CANCER

Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions

(2009) Christian L. Villiers et al.   JOURNAL OF NANOPARTICLE RESEARCH

Functionalized Nanoparticles with Long-Term Stability in Biological Media

(2009) Chen Fang et al.   Small

How Location Governs Toll-Like Receptor Signaling

(2009) Akanksha Chaturvedi et al.   TRAFFIC

Imagable 4T1 model for the study of late stage breast cancer

(2008) Kai Tao et al.   BMC CANCER

Metastatic Breast Cancer: The Treatment Challenge

(2008) Stephen E. Jones   Clinical Breast Cancer

The TLR3 agonist poly(I:C) targets CD8+ T cells and augments their antigen-specific responses upon their adoptive transfer into naïve recipient mice

(2008) Mohamed L. Salem et al.   VACCINE